The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic
In Japan, the University of Tsukuba started clinical research and development in the year 1983. This was the first university in Japan that facilitates research and development of proton therapy and it created various milestones at various levels like started treatment of multiple cancerous tumors and creating a worldwide standard of proton therapy etc. In Japan, the number of patients eligibility for proton therapy is much higher than the proton therapy center, which treated the patients. According to our research, Japan is the largest proton therapy hub in Asia. The Japan Proton Therapy Market potential is expected to cross US$ 6 Billion by the end of the year 2025.
Rising cancer prevalence, increasing aging population, growing per capita expenditure, increasing number of proton therapy center in Japan will further boost the proton therapy market in the future course of time. In the early time, proton therapy was used to treat specific kind of cancers like prostate, CNS etc. but now proton therapy technology can treat various cancer at every stage of life; from pediatric to adult and old age also.
Patients Insight – Japan Proton Therapy
This report contains full information about patients, who are likely to get treated with proton therapy, the actual number of patients who have received proton therapy treatment. Moreover we have also categorized the patients on the basis of disease or cancer type into 10 parts; Head and Neck Cancer, Central Nervous System (CNS) Tumors, GI (Gastro-Intestinal) Cancer, Hepatocellular Carcinoma (HCC), Pancreas Cancer, Prostate Cancer, Lung Cancer, Gynecologic Cancers, Bone and Soft Tissue Cancer, Others). We have also provided an in-depth analysis of proton therapy center in Japan, providing a treated patient number by each year and by each operational center in Japan.
Market Insight – Japan Proton Therapy
Japan is one of the largest hubs of proton therapy center in the Asian region. The rising technological development and increasing cutting-edge technology in radiotherapy in Japan will further propel the proton therapy market of Japan in the forecast period. Currently, Japan has XXXX operational proton therapy center and XXXX new under-constructional phase proton therapy center project. The rising new under-contraction proton therapy center in Japan due to cancer patient in Japan is increasing at a rapid pace, and it will continue in the future course of time.
Renub Research report Japan Proton Therapy Market, Patients by 10 Cancer Types (Central Nervous System (CNS), Head and Neck, Lung, GI (Gastro-Intestinal), Hepatocellular Carcinoma (HCC), Pancreas, Gynecologic, Prostate, Bone and Soft Tissue, Others) Reimbursement Policies & Persons Treated at Centers provides a comprehensive assessment of the fast-evolving, high-growth of Japan Proton Therapy Market.
The report studies the market and patients numbers, of 10 individual cancer types who are treated under proton therapy. The report also talks about the list of all operational and future Proton Therapy centers; Reimbursement Policies. The report also studies the Proton Therapy Revenue of 3 Companies.
Types of Proton Therapy Market (Actual & Untapped)
1. Actual Market is the current market which is already present.
2. Untapped Market is the market which can be achieved, but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.
Japan Proton Therapy Market has been analyzed from six viewpoints
1. Actual Market
2. Potential Market
3. Treated Patient Numbers
4. Untapped Patient Numbers
5. Cancer Type - Japan Proton Therapy Market
6. Cancer Type - Japan Proton Therapy Number of Patients
10 Types of Cancer Patient Numbers and Market in Japan Proton Therapy
1. Central Nervous System (CNS) Tumors
2. Head and Neck Cancer
3. Prostate Cancer
4. Lung Cancer
5. GI (Gastro-Intestinal) Cancer
6. Hepatocellular Carcinoma (HCC) Cancer
7. Pancreas Cancer
8. Gynecologic Cancers
9. Bone and Soft Tissue Cancer
10. Others Cancer
Key Companies Covered
1. IBA (Overview, Sales Analysis)
2. Varian Medical Systems (Overview, Sales Analysis)
3. Elekta (Overview, Sales Analysis)